Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
2.510
+0.170 (7.26%)
At close: Apr 28, 2026, 4:00 PM EDT
2.496
-0.014 (-0.57%)
After-hours: Apr 28, 2026, 7:19 PM EDT
Context Therapeutics Employees
Context Therapeutics had 15 employees as of December 31, 2025. The number of employees increased by 3 or 25.00% compared to the previous year.
Employees
15
Change (1Y)
3
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$2,408,241
Market Cap
230.62M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15 | 3 | 25.00% |
| Dec 31, 2024 | 12 | 7 | 140.00% |
| Dec 31, 2023 | 5 | -4 | -44.44% |
| Dec 31, 2022 | 9 | 8 | 800.00% |
| Dec 31, 2020 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| MacroGenics | 293 |
| Karyopharm Therapeutics | 228 |
| MediWound | 121 |
| Nkarta | 108 |
| Caribou Biosciences | 97 |
| OmniAb | 89 |
| Enlivex | 34 |
CNTX News
- 26 days ago - Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer - GlobeNewsWire
- 5 weeks ago - Context Therapeutics Reports Full Year 2025 Operating and Financial Results - GlobeNewsWire
- 5 weeks ago - Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026 - GlobeNewsWire
- 6 weeks ago - Context Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Context Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Context Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 months ago - Context Therapeutics Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference - Transcripts